Company Encyclopedia
View More
name
VanEck Retail ETF
RTH.US
News
View More

CVS Health Corp. Stock Underperforms Friday When Compared To Competitors

CVS Health Corp.'s stock fell 1.46% to $75.63 on Friday, underperforming compared to competitors like Amazon, which rose 0.18%. The stock is 11.18% below its 52-week high. Trading volume was slightly below the 50-day average. The S&P 500 and Dow Jones both saw gains during the session.

Dow Jones·
US
CVS
-1.46%
Dow Jones·
US
CVS
-1.46%

TJX Cos. Stock Outperforms Competitors On Strong Trading Day

TJX Cos. stock rose 1.98% to $153.28, outperforming competitors like Amazon, Walmart, and Target on a strong trading day. The stock is close to its 52-week high, with a trading volume surpassing its 50-day average. The S&P 500 and Dow Jones also saw gains.

Dow Jones·
US
TJX
+1.98%
Dow Jones·
US
TJX
+1.98%

Walmart gains for the eighth straight trading day

Walmart gains for the eighth straight trading day

businessinsider·
US
WMT
+0.24%
businessinsider·
US
WMT
+0.24%

Amazon had a very big week that could shape where its stagnant stock goes next

Amazon had a significant week with developments in cloud technology, logistics, AI investments, and grocery delivery. At the re:Invent 2025 conference, AWS unveiled the Trainium3 chip, enhancing performance and efficiency. Amazon may reconsider its USPS partnership, potentially improving margins. An Anthropic IPO could benefit Amazon, given its $8 billion investment. Additionally, Amazon is testing ultra-fast grocery delivery, expanding its market presence. These moves indicate strategic growth and innovation, despite challenges in AI competition and market performance.

CNBC·
US
AMZN
+0.18%
US
AMZU
+0.17%
CNBC·
US
AMZN
+0.18%
US
AMZU
+0.17%

Catalyst Watch: Spotlight on the Fed, Costco earnings, and Nasdaq 100 additions

Next week's financial events include Fed interest rate decision, Costco earnings, and Nasdaq 100 additions. Volatility expected for Bloom Energy and The Trade Desk. IPOs for Cardinal Infrastructure, Lumexa Imaging, and Wealthfront. Earnings reports from Toll Brothers, Autozone, Oracle, and Broadcom. Key investor conferences and FDA action on GSK's treatment. Microsoft to present at Barclays.

businessinsider·
US
COST
-0.13%
businessinsider·
US
COST
-0.13%
© 2025 Longbridge｜Disclaimer